Magnetic Resonance - Technology Information Portal Welcome to MRI Technology
Info
  Sheets

Out-
      side
 



 
 'Magnetic Resonance Angiography MRA' 
SEARCH FOR    
 
  2 3 5 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Result : Searchterm 'Magnetic Resonance Angiography MRA' found in 1 term [] and 1 definition [], (+ 15 Boolean[] results
1 - 5 (of 17)     next
Result Pages : [1]  [2 3 4]
Searchterm 'Magnetic Resonance Angiography MRA' was also found in the following services: 
spacer
News  (7)  Resources  (3)  
 
Magnetic Resonance Angiography MRAMRI Resource Directory:
 - MRA -
 
(MRA) Magnetic resonance angiography is a medical imaging technique to visualize blood filled structures, including arteries, veins and the heart chambers. This MRI technique creates soft tissue contrast between blood vessels and surrounding tissues primarily created by flow, rather than displaying the vessel lumen. There are bright blood and black blood MRA techniques, named according to the appearance of the blood vessels. With this different MRA techniques both, the blood flow and the condition of the blood vessel walls can be seen. Flow effects in MRI can produce a range of artifacts. MRA takes advantage of these artifacts to create predictable image contrast due to the nature of flow.
Technical parameters of the MRA sequence greatly affect the sensitivity of the images to flow with different velocities or directions, turbulent flow and vessel size.
This are the three main types of MRA:
All angiographic techniques differentially enhance vascular MR signal. The names of the bright blood techniques TOF and PCA reflect the physical properties of flowing blood that were exploited to make the vessels appear bright. Contrast enhanced magnetic resonance angiography creates the angiographic effect by using an intravenously administered MR contrast agent to selectively shorten the T1 of blood and thereby cause the vessels to appear bright on T1 weighted images.
MRA images optimally display areas of constant blood flow-velocity, but there are many situations where the flow within a voxel has non-uniform speed or direction. In a diseased vessel these patterns are even more complex. Similar loss of streamline flow occurs at all vessel junctions and stenoses, and in regions of mural thrombosis. It results in a loss of signal, due to the loss of phase coherence between spins in the voxel.
This signal loss, usually only noticeable distal to a stenosis, used to be an obvious characteristic of MRA images. It is minimized by using small voxels and the shortest possible TE. Signal loss from disorganized flow is most noticeable in TOF imaging but also affects the PCA images.
Indications to perform a magnetic resonance angiography (MRA):
Detection of aneurysms and dissections
Evaluation of the vessel anatomy, including variants
Blockage by a blood clot or stenosis of the blood vessel caused by plaques (the buildup of fat and calcium deposits)

Conventional angiography or computerized tomography angiography (CT angiography) may be needed after MRA if a problem (such as an aneurysm) is present or if surgery is being considered.

See also Magnetic Resonance Imaging MRI.
 
Images, Movies, Sliders:
 CE-MRA of the Carotid Arteries Colored MIP  Open this link in a new window
    
SlidersSliders Overview

 CE MRA of the Aorta  Open this link in a new window
    
SlidersSliders Overview

 TOF-MRA Circle of Willis Inverted MIP  Open this link in a new window
    

 PCA-MRA 3D Brain Venography Colored MIP  Open this link in a new window
    

 Circle of Willis, Time of Flight, MIP  Open this link in a new window
    
SlidersSliders Overview

 
Radiology-tip.comradCT Angiography,  Angiogram
spacer
Medical-Ultrasound-Imaging.comVascular Ultrasound,  Intravascular Ultrasound
spacer
 
• Share the entry 'Magnetic Resonance Angiography MRA':  Facebook  Twitter  LinkedIn  
 
• Related Searches:
    • Sensitivity Encoding
    • Cardiovascular Imaging
    • Black Blood MRA
    • Angiography
    • Blood Pool Agents
 
Further Reading:
  Basics:
Magnetic resonance angiography: current status and future directions
Wednesday, 9 March 2011   by www.jcmr-online.com    
MR–ANGIOGRAPHY(.pdf)
  News & More:
3-D-printed model of stenotic intracranial artery enables vessel-wall MRI standardization
Friday, 14 April 2017   by www.eurekalert.org    
Conventional MRI and MR Angiography of Stroke
2012   by www.mc.vanderbilt.edu    
MR Angiography Highly Accurate In Detecting Blocked Arteries
Thursday, 1 February 2007   by www.sciencedaily.com    
Searchterm 'Magnetic Resonance Angiography MRA' was also found in the following service: 
spacer
Radiology  (2) Open this link in a new window
Lantheus Medical Imaging, Inc.
 
www.radiopharm.com Lantheus Medical Imaging is a worldwide leader in medical imaging, with headquarters in North Billerica, Massachusetts, and nearly 700 employees worldwide with offices in Puerto Rico, Canada, and Australia.
The product portfolio includes ABLAVAR™ (gadofosveset trisodium) a blood pool contrast agent for magnetic resonance angiography MRA, Cardiolite® (Kit for the preparation of Technetium Tc99m Sestamibi), a cardiac perfusion imaging agent and DEFINITY® Vial for (Perflutren Lipid Microsphere) injectable suspension, the leading cardiac ultrasound contrast agent in the US.

MRI Contrast Agents:
Contact Information
MAIL
Lantheus Medical Imaging
Bldg. 200-2, 331 Treble Cove Rd.
N. Billerica, MA 01862
USA
PHONE
+1-800-362-2668
FAX
+1-978-436-7501
spacer

• View the DATABASE results for 'Lantheus Medical Imaging, Inc.' (3).Open this link in a new window


• View the NEWS results for 'Lantheus Medical Imaging, Inc.' (5).Open this link in a new window.
MRI Resources 
NMR - MRI Accidents - Devices - IR - Libraries - Raman Spectroscopy
 
Intera 1.5TPanorama 0.2InfoSheet: - Devices -
Intro, 
Types of Magnets, 
Overview, 
etc.MRI Resource Directory:
 - Devices -
 
www.medical.philips.com/de/products/mri/products/ From Philips Medical Systems;
the Intera-family offers with this member a wide range of possibilities, efficiency and a ergonomic and intuitive serving-platform. Also available as Intera CV for cardiac and Intera I/T for interventional MR procedures.
The scanners are also equipped with SENSE technology, which is essential for high-quality contrast enhanced magnetic resonance angiography, interactive cardiac MR and diffusion tensor imaging (DTI) fiber tracking.
The increased accuracy and clarity of MR scans obtained with this technology allow for faster and more accurate diagnosis of potential problems like patient friendliness and expands the breadth of applications including cardiology, oncology and interventional MR.
Device Information and Specification
CLINICAL APPLICATION
Whole body
CONFIGURATION
Short bore compact
Standard: head, body, C1, C3; Optional: Small joint, flex-E, flex-R, endocavitary (L and S), dual TMJ, knee, neck, T/L spine, breast; Optional phased array: Spine, pediatric, 3rd party connector; Optional SENSE coils: Flex-S-M-L, flex body, flex cardiac
Optional
SYNCHRONIZATION
ECG/peripheral: Optional/yes, respiratory gating
PULSE SEQUENCES
SE, Modified-SE (TSE), IR (T1, T2, PD), STIR, FLAIR, SPIR, FFE, T1-FFE, T2-FFE, Balanced FFE, TFE, Balanced TFE, Dynamic, Keyhole, 3D, Multi Chunk 3D, Multi Stack 3D, K Space Shutter, MTC, TSE, Dual IR, DRIVE, EPI, Cine, 2DMSS, DAVE, Mixed Mode; Angiography: PCA, MCA, Inflow MRA, CE
IMAGING MODES
Single Slice 2D , Multi Single Slice 2D, Multi Slice 2D, 3D, Multi Chunk 3D, Multi Stack 3D
TR
2.9 (Omni), 1.6 (Power), 1.6 (Master/Expl) msec
TE
1.0 (Omni), 0.7 (Power), 0.5 (Master/Expl) msec
SINGLE/MULTI SLICE
RapidView Recon. greater than 500 @ 256 Matrix
FOV
Max. 53 cm
0.1 mm(Omni), 0.05 mm (Pwr/Mstr/Expl)
128 x 128, 256 x 256,512 x 512,1024 x 1024 (64 for BOLD img.)
MEASURING MATRIX
Variable in 1% increments
PIXEL INTENSITY
Lum.: 120 cd/m2; contrast: 150:1
Variable (op. param. depend.)
60 cm diameter (patient)
MAGNET WEIGHT
2900 kg
H*W*D
240 x 188 x 157 cm
POWER REQUIREMENTS
380/400 V
CRYOGEN USE
0.03 L/hr helium
STRENGTH
30 mT/m
5-GAUSS FRINGE FIELD
2.4 m / 3.8 m
Passive and dynamic
spacer

• View the DATABASE results for 'Intera 1.5T™' (2).Open this link in a new window

Searchterm 'Magnetic Resonance Angiography MRA' was also found in the following services: 
spacer
News  (7)  Resources  (3)  
 
ABLAVAR™InfoSheet: - Contrast Agents - 
Intro, Overview, 
Characteristics, 
Types of, 
etc.
 
ABLAVAR™ (formerly named Vasovist™) is a blood pool agent for magnetic resonance angiography (MRA), which opens new medical imaging possibilities in the evaluation of aortoiliac occlusive disease (AIOD) in patients with suspected peripheral vascular disease.
ABLAVAR™ binds reversibly to blood albumin, providing imaging with high spatial resolution up to 1 hour after injection, due to its high relaxivity and to the long lasting increased signal intensity of blood.
As with other contrast media: the possibility of serious or life-threatening anaphylactic or anaphylactoid reactions, including cardiovascular, respiratory and/or cutaneous manifestations, should always be considered.

WARNING:
NEPHROGENIC SYSTEMIC FIBROSIS
Gadolinium-based contrast agents increase the risk for nephrogenic systemic fibrosis (NSF) in patients with acute or chronic severe renal insufficiency (glomerular filtration rate less than 30 mL/min/1.73m2), or acute renal insufficiency of any severity due to the hepato-renal syndrome or in the perioperative liver transplantation period.

See also Cardiovascular Imaging, Adverse Reaction, Molecular Imaging, and MRI Safety.
Drug Information and Specification
NAME OF COMPOUND
Diphenylcyclohexyl phosphodiester-Gd-DTPA, gadofosveset trisodium, MS-325
CENTRAL MOIETY
Gd2+
CONTRAST EFFECT
T1, predominantly positive enhancement
20-45 mmol-1sec-1, Bo=0,47T
PHARMACOKINETIC
Intravascular
825 mOsmol/kg H2O
CONCENTRATION
244 mg/mL, 0.25mmol/mL
DOSAGE
0.12 mL/kg, 0.03 mmol/kg
PREPARATION
ready to use
DEVELOPMENT STAGE
FDA approved
DISTRIBUTOR
See below
PRESENTATION
10 mL vials
DO NOT RELY ON THE INFORMATION PROVIDED HERE, THEY ARE
NOT A SUBSTITUTE FOR THE ACCOMPANYING PACKAGE INSERT!
Distribution Information
TERRITORY
TRADE NAME
DEVELOPMENT
STAGE
DISTRIBUTOR
EU
Approved
USA, Canada, Australia
ABLAVAR™
Approved
spacer

• View the DATABASE results for 'ABLAVAR™' (3).Open this link in a new window


• View the NEWS results for 'ABLAVAR™' (1).Open this link in a new window.
 
Further Reading:
  Basics:
Ablavar Prescribing Information
   by www.ablavar.com    
  News & More:
The first FDA-approved blood-pool MR agent offers additional time for imaging and possibly some new applications
Thursday, 1 July 2010   by www.radiologytoday.net    
Searchterm 'Magnetic Resonance Angiography MRA' was also found in the following service: 
spacer
Radiology  (2) Open this link in a new window
Contrast Enhanced MRIInfoSheet: - Contrast Agents - 
Intro, Overview, 
Characteristics, 
Types of, 
etc.MRI Resource Directory:
 - Contrast Enhanced MRI -
 
Contrast enhanced MRI is a commonly used procedure in magnetic resonance imaging. The need to more accurately characterize different types of lesions and to detect all malignant lesions is the main reason for the use of intravenous contrast agents.
Some methods are available to improve the contrast of different tissues. The focus of dynamic contrast enhanced MRI (DCE-MRI) is on contrast kinetics with demands for spatial resolution dependent on the application. DCE-MR imaging is used for diagnosis of cancer (see also liver imaging, abdominal imaging, breast MRI, dynamic scanning) as well as for diagnosis of cardiac infarction (see perfusion imaging, cardiac MRI). Quantitative DCE-MRI requires special data acquisition techniques and analysis software.
Contrast enhanced magnetic resonance angiography (CE-MRA) allows the visualization of vessels and the temporal resolution provides a separation of arteries and veins. These methods share the need for acquisition methods with high temporal and spatial resolution.
Double contrast administration (combined contrast enhanced (CCE) MRI) uses two contrast agents with complementary mechanisms e.g., superparamagnetic iron oxide to darken the background liver and gadolinium to brighten the vessels. A variety of different categories of contrast agents are currently available for clinical use.
Reasons for the use of contrast agents in MRI scans are:
Relaxation characteristics of normal and pathologic tissues are not always different enough to produce obvious differences in signal intensity.
Pathology that is sometimes occult on unenhanced images becomes obvious in the presence of contrast.
Enhancement significantly increases MRI sensitivity.
In addition to improving delineation between normal and abnormal tissues, the pattern of contrast enhancement can improve diagnostic specificity by facilitating characterization of the lesion(s) in question.
Contrast can yield physiologic and functional information in addition to lesion delineation.
Imaging of arteries and veins with contrast enhanced angiography (CE MRA).

Common Indications:
Brain MRI : Preoperative/pretreatment evaluation and postoperative evaluation of brain tumor therapy, CNS infections, noninfectious inflammatory disease and meningeal disease.
Spine MRI : Infection/inflammatory disease, primary tumors, drop metastases, initial evaluation of syrinx, postoperative evaluation of the lumbar spine: disk vs. scar.
Breast MRI : Detection of breast cancer in case of dense breasts, implants, malignant lymph nodes, or scarring after treatment for breast cancer, diagnosis of a suspicious breast lesion in order to avoid biopsy.

For Ultrasound Imaging (USI) see Contrast Enhanced Ultrasound at Medical-Ultrasound-Imaging.com. See also Blood Pool Agents, Myocardial Late Enhancement, Cardiovascular Imaging, Contrast Enhanced MR Venography, Contrast Resolution, Dynamic Scanning, Lung Imaging, Hepatobiliary Contrast Agents, Contrast Medium and MRI Guided Biopsy.
 
Images, Movies, Sliders:
 Delayed Myocardial Contrast Enhancement from Infarct  Open this link in a new window
      

Courtesy of  Robert R. Edelman
 Left Circumflex Ischemia First-pass Contrast Enhancement  Open this link in a new window
      

Courtesy of  Robert R. Edelman

 Normal Lung Gd Perfusion MRI  Open this link in a new window
 MRI of the Brain Stem with Temoral Bone and Auditory System  Open this link in a new window
    
SlidersSliders Overview

 Breast MRI Images T1 Pre - Post Contrast  Open this link in a new window
 
Radiology-tip.comradContrast Enhanced Computed Tomography
spacer
Medical-Ultrasound-Imaging.comContrast Enhanced Ultrasound,  Contrast Enhanced Doppler Imaging
spacer

• View the DATABASE results for 'Contrast Enhanced MRI' (14).Open this link in a new window


• View the NEWS results for 'Contrast Enhanced MRI' (8).Open this link in a new window.
 
Further Reading:
  Basics:
Optimal k-Space Sampling for Dynamic Contrast-Enhanced MRI with an Application to MR Renography
Thursday, 5 November 2009   by www.ncbi.nlm.nih.gov    
  News & More:
FDA Approves Gadopiclenol for Contrast-Enhanced Magnetic Resonance Imaging
Tuesday, 27 September 2022   by www.pharmacytimes.com    
Effect of gadolinium-based contrast agent on breast diffusion-tensor imaging
Thursday, 6 August 2020   by www.eurekalert.org    
Artificial Intelligence Processes Provide Solutions to Gadolinium Retention Concerns
Thursday, 30 January 2020   by www.itnonline.com    
Accuracy of Unenhanced MRI in the Detection of New Brain Lesions in Multiple Sclerosis
Tuesday, 12 March 2019   by pubs.rsna.org    
The Effects of Breathing Motion on DCE-MRI Images: Phantom Studies Simulating Respiratory Motion to Compare CAIPIRINHA-VIBE, Radial-VIBE, and Conventional VIBE
Tuesday, 7 February 2017   by www.kjronline.org    
Novel Imaging Technique Improves Prostate Cancer Detection
Tuesday, 6 January 2015   by health.ucsd.edu    
New oxygen-enhanced MRI scan 'helps identify most dangerous tumours'
Thursday, 10 December 2015   by www.dailymail.co.uk    
All-organic MRI Contrast Agent Tested In Mice
Monday, 24 September 2012   by cen.acs.org    
A groundbreaking new graphene-based MRI contrast agent
Friday, 8 June 2012   by www.nanowerk.com    
MRI Resources 
Blood Flow Imaging - Claustrophobia - Diffusion Weighted Imaging - Safety pool - Spectroscopy - Calculation
 
     1 - 5 (of 17)     next
Result Pages : [1]  [2 3 4]
 Random Page
 
Share This Page
FacebookTwitterLinkedIn

MR-TIP    
Community   
User
Pass
Forgot your UserID/Password ?    



New acceleration techniques will :
reduce scan times 
cause artifacts 
increase expenses 
be useful if you have a lot of experience 
doesn't do much 
never heard of 

Look
      Ups





MR-TIP.com uses cookies! By browsing MR-TIP.com, you agree to our use of cookies.

Magnetic Resonance - Technology Information Portal
Member of SoftWays' Medical Imaging Group - MR-TIP • Radiology-TIP • Medical-Ultrasound-Imaging • 
Copyright © 2003 - 2024 SoftWays. All rights reserved. [ 19 March 2024]
Terms of Use | Privacy Policy | Advertising
 [last update: 2024-02-26 03:41:00]